Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Operational Update for Phorm China

19 Nov 2013 07:00

RNS Number : 3497T
Phorm Corporation Limited
19 November 2013
 



19 November 2013

 

Phorm Corporation Limited ("Phorm" or the "Company")

 

Operational Update for Phorm China, User Numbers Reach 10m

 

Phorm (AIM: PHRM), a leading internet personalization technology company, announces today that it is making excellent progress towards commercial launch in the People's Republic of China.

 

· Nation-wide opt-in process is continuing

· Daily user numbers since launch have reached over 10m per day

· Two major inventory deals signed providing access to hundreds of publishers

· Negotiations continuing with further publishers and advertisers

· Solution deployment in progress with two further ISPs

 

Phorm previously announced on 3 October that it had started a nation-wide opt-in process in China and that it had approximately 4.3m users per day. The Company is very pleased to announce that the opt-in process has continued to be extremely successful and that the number of daily users since launch has reached over 10m per day.

 

The Company has also concluded two major inventory deals that provide access to hundreds of publishers. Commercial discussions with both publishers and advertisers are continuing and the proposition is being very well received.

 

The Company is now progressing towards its first test campaigns before moving to commercial operations.

 

-ends-

 

Contact

 

Phorm Corporation Limited

 

Andy Croxson (analysts & investors) +44 207 297 2067

 

UK Investors

Mirabaud Securities LLP +44 20 7321 2508 (Joint Broker)

 

Jason Woollard

Peter Krens

 

Liberum Capital +44 20 3100 2222 (Nominated Advisor and Joint Broker)

 

Chris Bowman

Richard Bootle

 

US Investors

Lippert Heilshorn and Associates +1 212 838 3777 (Investor Relations)

 

John Heilshorn

 

About Phorm

 

Phorm is a global personalization technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience.

 

Phorm's industry leading technology enables its ISP partners to offer a new type of online advertising platform and a free consumer internet content feature, ensuring more relevant advertisements and personalized content for opted-in users.

 

Phorm's advertising platform revolutionizes current standards of online privacy, fully protecting the identity of consumers. Unlike virtually all other targeted advertising propositions, Phorm's solution is completely opt-in. Only those users consenting to the service are profiled and only ever on an anonymous basis.

 

Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Advertising Networks and Advertisers.

 

Phorm, under a predecessor holding company, was admitted to the AIM market of the London Stock Exchange in 2004.

 

For more information, please visit: www.phorm.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUWVOROBAAAUA
Date   Source Headline
5th Jan 20107:00 amRNSTransfer of shares
17th Dec 200911:51 amRNSPurchase of Shares and Total Voting Rights
4th Nov 20092:18 pmRNSNotification of major interest in shares
2nd Nov 200912:42 pmRNSResult of AGM
6th Oct 20092:07 pmRNSNotice of AGM
2nd Oct 20097:00 amRNSNotification of major interest in shares
21st Sep 20097:00 amRNSInterim results
14th Sep 20098:57 amRNSNotification of Results
5th Aug 20097:00 amRNSTransfer of Shares
8th Jul 20098:27 amRNSOperational Update
6th Jul 20099:22 amRNSStatement on UK operations
30th Jun 20097:13 amRNSAnnual Accounts
19th Jun 200911:06 amRNSTotal Voting Rights
18th Jun 20097:00 amRNSFinal Results
10th Jun 20097:00 amRNSPlacing to raise ?15 million
3rd Jun 200911:00 amRNSPhorm announces Webwise Discover
21st May 20097:00 amRNSKorean Market Trial
27th Apr 200910:31 amRNSStatement re Apology from "New Media Age" Magazine
14th Apr 20096:23 pmRNSPhorm Statement re EU Commission
9th Apr 20093:57 pmRNSAIM Block Admission
30th Mar 20097:00 amRNSKorean Market Trial
26th Mar 20097:03 amRNSGrant of Options
19th Mar 20091:31 pmRNSGrant of Options
18th Mar 20097:00 amRNSChange of Broker
13th Mar 20095:03 pmRNSShare Issue - Replacement
13th Mar 20092:46 pmRNSShare Issue
11th Mar 20099:49 amRNSAnnouncement of Appointments
4th Mar 20093:18 pmRNSCity Events Wire
17th Dec 20085:52 pmRNSManagement Appointments
15th Dec 20087:00 amRNSBT Trial Update
1st Dec 20087:00 amRNSPhorm Announces Board Changes
5th Nov 20087:46 amRNSDisclosure of Share Sale
22nd Oct 20085:14 pmRNSGrant of options
14th Oct 200810:15 amRNSCancellation of admission of shares
30th Sep 20087:00 amRNSInterim Results
29th Sep 20087:00 amRNSCommencement of BT Trial
22nd Sep 200811:15 amRNSResponse to Statement by BERR
4th Sep 20087:00 amRNSPhorm Update
18th Aug 20087:00 amRNSAppointment of Independent Bo
24th Jun 20087:00 amRNSTransfer of Shares
14th May 20084:45 pmRNSExercise of Options
14th May 200812:55 pmRNSAnnual Report and Accounts
10th Apr 20087:01 amRNSFinal Results
4th Apr 20084:23 pmRNSNotification of Holding
4th Apr 20084:16 pmRNSNotification Of Shareholding
4th Apr 200812:11 pmRNSNotification Of Shareholding
19th Mar 20087:01 amRNSIssue of Equity
13th Mar 200811:32 amRNSResult of Stockholder Meeting
11th Mar 20087:02 amRNSRe Share Price Movement
28th Feb 20085:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.